These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17189954

  • 41. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK, Adams MT, Motta J.
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [Abstract] [Full Text] [Related]

  • 42. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [Abstract] [Full Text] [Related]

  • 43. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
    Stock RG, Kao J, Stone NN.
    J Urol; 2001 Feb; 165(2):436-9. PubMed ID: 11176391
    [Abstract] [Full Text] [Related]

  • 44. Cross-sectional analysis of sexual function after prostate brachytherapy.
    Finney G, Haynes AM, Cross P, Brenner P, Boyn A, Stricker P.
    Urology; 2005 Aug; 66(2):377-81. PubMed ID: 16098365
    [Abstract] [Full Text] [Related]

  • 45. Patient and treatment factors associated with complications after prostate brachytherapy.
    Chen AB, D'Amico AV, Neville BA, Earle CC.
    J Clin Oncol; 2006 Nov 20; 24(33):5298-304. PubMed ID: 17114664
    [Abstract] [Full Text] [Related]

  • 46. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1053-8. PubMed ID: 17398023
    [Abstract] [Full Text] [Related]

  • 47. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A, Fabbri F, Salonia A, Gallina A, Chun FK, Dehò F, Zanni G, Suardi N, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2007 Sep 15; 52(3):702-7. PubMed ID: 17418936
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Erectile dysfunction after radiotherapy for prostate cancer.
    Mendenhall WM, Henderson RH, Indelicato DJ, Keole SR, Mendenhall NP.
    Am J Clin Oncol; 2009 Aug 15; 32(4):443-7. PubMed ID: 19657239
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy.
    Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M.
    BJU Int; 2007 Oct 15; 100(4):858-62. PubMed ID: 17822466
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer.
    Asterling S, Greene DR.
    BJU Int; 2009 Mar 15; 103(6):788-92. PubMed ID: 18793299
    [Abstract] [Full Text] [Related]

  • 54. [Sexual dysfunction after curietherapy and external radiotherapy of the prostate for localized prostate cancer].
    Huyghe E, Bachaud JM, Achard JL, Bossi A, Droupy S, les membres du comité d'andrologie de l'AFU.
    Prog Urol; 2009 Dec 15; 19 Suppl 4():S173-6. PubMed ID: 20123514
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS.
    J Natl Cancer Inst; 2009 Jun 16; 101(12):888-92. PubMed ID: 19509365
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H.
    Cancer; 2007 Apr 15; 109(8):1506-12. PubMed ID: 17340591
    [Abstract] [Full Text] [Related]

  • 59. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
    Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, Webb S, Khoo VS, MRC RT01 Trial Management Group, Dearnaley DP.
    Radiother Oncol; 2006 Sep 15; 80(3):355-62. PubMed ID: 16949694
    [Abstract] [Full Text] [Related]

  • 60. An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer.
    Marina O, Warner J, Ye H, Grills IS, Shah C, Wallace M, Gustafson GS, Brabbins DS, Martinez AA, Krauss DJ.
    Brachytherapy; 2014 Sep 15; 13(2):163-8. PubMed ID: 24295963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.